Annual Total Liabilities:
$22.18M-$4.32M(-16.31%)Summary
- As of today, NAGE annual total liabilities is $22.18 million, with the most recent change of -$4.32 million (-16.31%) on December 31, 2024.
- During the last 3 years, NAGE annual total liabilities has fallen by -$3.93 million (-15.05%).
- NAGE annual total liabilities is now -16.31% below its all-time high of $26.51 million, reached on December 31, 2023.
Performance
NAGE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Liabilities:
$27.46M+$133.00K(+0.49%)Summary
- As of today, NAGE quarterly total liabilities is $27.46 million, with the most recent change of +$133.00 thousand (+0.49%) on September 30, 2025.
- Over the past year, NAGE quarterly total liabilities has increased by +$5.31 million (+23.97%).
- NAGE quarterly total liabilities is now -6.58% below its all-time high of $29.40 million, reached on June 1, 2019.
Performance
NAGE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NAGE Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -16.3% | +24.0% |
| 3Y3 Years | -15.1% | +11.4% |
| 5Y5 Years | +12.0% | +53.2% |
NAGE Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -16.3% | at low | at high | +24.0% |
| 5Y | 5-Year | -16.3% | +12.0% | at high | +53.2% |
| All-Time | All-Time | -16.3% | >+9999.0% | -6.6% | >+9999.0% |
NAGE Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $27.46M(+0.5%) |
| Jun 2025 | - | $27.33M(+5.1%) |
| Mar 2025 | - | $25.99M(+17.2%) |
| Dec 2024 | $22.18M(-16.3%) | $22.18M(+0.1%) |
| Sep 2024 | - | $22.15M(-5.0%) |
| Jun 2024 | - | $23.32M(-7.2%) |
| Mar 2024 | - | $25.13M(-5.2%) |
| Dec 2023 | $26.51M(+4.4%) | - |
| Dec 2023 | - | $26.51M(+1.3%) |
| Sep 2023 | - | $26.18M(+0.6%) |
| Jun 2023 | - | $26.02M(+1.0%) |
| Mar 2023 | - | $25.75M(+1.4%) |
| Dec 2022 | $25.39M(-2.8%) | $25.39M(+3.0%) |
| Sep 2022 | - | $24.64M(-4.6%) |
| Jun 2022 | - | $25.84M(-4.5%) |
| Mar 2022 | - | $27.05M(+3.6%) |
| Dec 2021 | $26.11M(+19.1%) | $26.11M(+4.4%) |
| Sep 2021 | - | $25.00M(+5.5%) |
| Jun 2021 | - | $23.70M(-5.8%) |
| Mar 2021 | - | $25.16M(+14.7%) |
| Dec 2020 | $21.93M(+10.8%) | $21.93M(+22.3%) |
| Sep 2020 | - | $17.93M(-12.2%) |
| Jun 2020 | - | $20.41M(+7.1%) |
| Mar 2020 | - | $19.06M(-3.7%) |
| Dec 2019 | $19.80M(+31.5%) | $19.80M(+23.8%) |
| Sep 2019 | - | $16.00M(-45.6%) |
| Jun 2019 | - | $29.40M(+40.3%) |
| Mar 2019 | - | $20.95M(+39.2%) |
| Dec 2018 | $15.05M(+69.3%) | $15.05M(+10.5%) |
| Sep 2018 | - | $13.62M(+16.7%) |
| Jun 2018 | - | $11.67M(+8.2%) |
| Mar 2018 | - | $10.78M(+21.3%) |
| Dec 2017 | $8.89M(-9.1%) | $8.89M(+10.2%) |
| Sep 2017 | - | $8.06M(+12.0%) |
| Jun 2017 | - | $7.20M(-38.3%) |
| Mar 2017 | - | $11.68M(+19.4%) |
| Dec 2016 | $9.78M | $9.78M(+41.6%) |
| Sep 2016 | - | $6.91M(+29.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $5.33M(-47.2%) |
| Mar 2016 | - | $10.11M(-25.0%) |
| Dec 2015 | $13.47M(+77.1%) | $13.47M(+25.8%) |
| Sep 2015 | - | $10.71M(+3.7%) |
| Jun 2015 | - | $10.33M(+41.5%) |
| Mar 2015 | - | $7.30M(-4.1%) |
| Dec 2014 | $7.61M(+129.1%) | $7.61M(+81.4%) |
| Sep 2014 | - | $4.20M(-8.0%) |
| Jun 2014 | - | $4.56M(+24.0%) |
| Mar 2014 | - | $3.68M(+10.7%) |
| Dec 2013 | $3.32M(-34.1%) | $3.32M(-26.4%) |
| Sep 2013 | - | $4.51M(+20.2%) |
| Jun 2013 | - | $3.75M(-5.8%) |
| Mar 2013 | - | $3.98M(-21.0%) |
| Dec 2012 | $5.04M(+35.9%) | $5.04M(+20.0%) |
| Sep 2012 | - | $4.20M(-8.5%) |
| Jun 2012 | - | $4.59M(-1.4%) |
| Mar 2012 | - | $4.66M(+25.6%) |
| Dec 2011 | $3.71M(+136.0%) | $3.71M(+34.7%) |
| Sep 2011 | - | $2.75M(+6.5%) |
| Jun 2011 | - | $2.58M(+17.7%) |
| Mar 2011 | - | $2.20M(+39.8%) |
| Dec 2010 | $1.57M(-37.6%) | $1.57M(-16.7%) |
| Sep 2010 | - | $1.89M(+4.3%) |
| Jun 2010 | - | $1.81M(-42.7%) |
| Mar 2010 | - | $3.15M(+25.3%) |
| Dec 2009 | $2.52M(+7.9%) | $2.52M(+5.0%) |
| Sep 2009 | - | $2.40M(+3.9%) |
| Jun 2009 | - | $2.31M(-4.2%) |
| Mar 2009 | - | $2.41M(+3.2%) |
| Dec 2008 | $2.33M(>+9900.0%) | $2.33M(-27.1%) |
| Sep 2008 | - | $3.20M(-5.5%) |
| Jun 2008 | - | $3.39M(>+9900.0%) |
| Feb 2008 | - | $3300.00(+725.0%) |
| Nov 2007 | $400.00(-20.0%) | $400.00(-20.0%) |
| Aug 2007 | - | $500.00(0.0%) |
| May 2007 | - | $500.00(0.0%) |
| Feb 2007 | - | $500.00 |
| Nov 2006 | $500.00 | - |
FAQ
- What is Niagen Bioscience, Inc. annual total liabilities?
- What is the all-time high annual total liabilities for Niagen Bioscience, Inc.?
- What is Niagen Bioscience, Inc. annual total liabilities year-on-year change?
- What is Niagen Bioscience, Inc. quarterly total liabilities?
- What is the all-time high quarterly total liabilities for Niagen Bioscience, Inc.?
- What is Niagen Bioscience, Inc. quarterly total liabilities year-on-year change?
What is Niagen Bioscience, Inc. annual total liabilities?
The current annual total liabilities of NAGE is $22.18M
What is the all-time high annual total liabilities for Niagen Bioscience, Inc.?
Niagen Bioscience, Inc. all-time high annual total liabilities is $26.51M
What is Niagen Bioscience, Inc. annual total liabilities year-on-year change?
Over the past year, NAGE annual total liabilities has changed by -$4.32M (-16.31%)
What is Niagen Bioscience, Inc. quarterly total liabilities?
The current quarterly total liabilities of NAGE is $27.46M
What is the all-time high quarterly total liabilities for Niagen Bioscience, Inc.?
Niagen Bioscience, Inc. all-time high quarterly total liabilities is $29.40M
What is Niagen Bioscience, Inc. quarterly total liabilities year-on-year change?
Over the past year, NAGE quarterly total liabilities has changed by +$5.31M (+23.97%)